476 related articles for article (PubMed ID: 15569863)
1. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase.
Hacke W; Albers G; Al-Rawi Y; Bogousslavsky J; Davalos A; Eliasziw M; Fischer M; Furlan A; Kaste M; Lees KR; Soehngen M; Warach S;
Stroke; 2005 Jan; 36(1):66-73. PubMed ID: 15569863
[TBL] [Abstract][Full Text] [Related]
2. Low-dose intravenous recombinant tissue plasminogen activator in acute ischemic stroke without large vessel occlusion screened by 3T MRI.
Huynh QS; Tran CC; Nguyen-Thi HT; Nguyen TT; Phan-Thi HL; Luu-Dang DT; Le MT; Nguyen MD
Eur Rev Med Pharmacol Sci; 2023 Jul; 27(14):6554-6562. PubMed ID: 37522667
[TBL] [Abstract][Full Text] [Related]
3. Intravenous Thrombolysis is Effective in Mild Stroke Patients with an Admission NIHSS Score of 3 to 5.
Zhang K; Han L
Curr Neurovasc Res; 2023; 20(4):434-442. PubMed ID: 37909432
[TBL] [Abstract][Full Text] [Related]
4. Intravenous Odatroltide for Acute Ischemic Stroke Within 24 Hours of Onset: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study.
Chao AC; Lee TH; Pettigrew LC; Hannawi Y; Huang HY; Chi NF; Chan L; Chen PL; Devlin T
Drug Des Devel Ther; 2024; 18():2033-2042. PubMed ID: 38859883
[TBL] [Abstract][Full Text] [Related]
5. Thrombolysis with Recombinant Human Prourokinase 4.5-6 h After Acute Ischemic Stroke: A Phase IIa, Randomized, and Open-Label Multicenter Clinical Trial.
Song H; Wang Y; Ma Q; Chen H; Liu B; Yang Y; Zhu J; Zhao S; Jin X; Li Y; Wang Y; Zhu R; Zhao L; Liu J; Feng W; Liu R; Ji X; Wang Y
CNS Drugs; 2024 Jan; 38(1):67-75. PubMed ID: 38030867
[TBL] [Abstract][Full Text] [Related]
6. Symptomatic Intracranial Hemorrhage After Endovascular Stroke Treatment: External Validation of Prediction Models.
van der Ende NAM; Kremers FCC; van der Steen W; Venema E; Kappelhof M; Majoie CBLM; Postma AA; Boiten J; van den Wijngaard IR; van der Lugt A; Dippel DWJ; Roozenbeek B;
Stroke; 2023 Feb; 54(2):476-487. PubMed ID: 36689584
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Butylphthalide in Patients With Acute Ischemic Stroke: A Randomized Clinical Trial.
Wang A; Jia B; Zhang X; Huo X; Chen J; Gui L; Cai Y; Guo Z; Han Y; Peng Z; Jing P; Chen Y; Liu Y; Yang Y; Wang F; Sun Z; Li T; Sun H; Yuan H; Shao H; Gao L; Zhang P; Wang F; Cao X; Shi W; Li C; Yang J; Zhang H; Wang F; Deng J; Liu Y; Deng W; Song C; Chen H; He L; Zhao H; Li X; Yang H; Zhou Z; Wang Y; Miao Z;
JAMA Neurol; 2023 Aug; 80(8):851-859. PubMed ID: 37358859
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Intravenous rtPA in Ischemic Strokes Due to Small-Vessel Occlusion: Systematic Review and Meta-Analysis.
Karaszewski B; Wyszomirski A; Jabłoński B; Werring DJ; Tomaka D
Transl Stroke Res; 2021 Jun; 12(3):406-415. PubMed ID: 33641037
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Urinary Kallidinogenase Plus Intravenous Recombinant Tissue Plasminogen Activator for Stroke Patients With Extended Window: A Retrospective Analysis.
Li X; Zhang X; Yang Y; Wang H; Zhang J
Neurologist; 2023 Nov; 28(6):373-378. PubMed ID: 37247414
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic Stem Cell Therapy for Acute Ischemic Stroke: The Phase 2/3 TREASURE Randomized Clinical Trial.
Houkin K; Osanai T; Uchiyama S; Minematsu K; Taguchi A; Maruichi K; Niiya Y; Asaoka K; Kuga Y; Takizawa K; Haraguchi K; Yoshimura S; Kimura K; Tokunaga K; Aoyama A; Ikawa F; Inenaga C; Abe T; Tominaga A; Takahashi S; Kudo K; Fujimura M; Sugiyama T; Ito M; Kawabori M; Hess DC; Savitz SI; Hirano T;
JAMA Neurol; 2024 Feb; 81(2):154-162. PubMed ID: 38227308
[TBL] [Abstract][Full Text] [Related]
11. Intravenous thrombolysis for acute ischemic stroke: why not?
Psychogios K; Tsivgoulis G
Curr Opin Neurol; 2022 Feb; 35(1):10-17. PubMed ID: 34799512
[TBL] [Abstract][Full Text] [Related]
12. RhPro-UK in acute ischemic stroke within 4.5 hours of stroke onset trial-2(The PROST-2 study): Rationale and design of a multicenter, prospective, randomized, open-label, blinded-endpoint, controlled phase 3 non-inferiority trial.
Li S; Gu HQ; Feng B; Dong Q; Fan D; Xu Y; Zhu SQ; Wang Y
Int J Stroke; 2024 Jun; ():17474930241265654. PubMed ID: 38907679
[TBL] [Abstract][Full Text] [Related]
13. Intravenous tirofiban following successful reperfusion in intracranial large artery atherosclerotic stroke: A secondary analysis of a randomized clinical trial.
Huang J; Kong W; Liu C; Song J; Yang J; Yue C; Li L; Hu J; Tian Y; Peng Z; Guo C; Yang D; Liu X; Miao J; Zhang X; Li F; Saver JL; Zi W
Ann Clin Transl Neurol; 2023 Nov; 10(11):2043-2052. PubMed ID: 37649303
[TBL] [Abstract][Full Text] [Related]
14. MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study.
Lansberg MG; Straka M; Kemp S; Mlynash M; Wechsler LR; Jovin TG; Wilder MJ; Lutsep HL; Czartoski TJ; Bernstein RA; Chang CW; Warach S; Fazekas F; Inoue M; Tipirneni A; Hamilton SA; Zaharchuk G; Marks MP; Bammer R; Albers GW;
Lancet Neurol; 2012 Oct; 11(10):860-7. PubMed ID: 22954705
[TBL] [Abstract][Full Text] [Related]
15. Predictors of Postthrombolysis Outcome and Symptomatic Postthrombolysis Hemorrhage following Intravenous Thrombolysis with Alteplase for Acute Ischemic Stroke.
Das S; Mondal GP; Bhattacharya R; Ghosh KC; Das S; Pattem HK; Paul SA; Patra C
J Neurosci Rural Pract; 2020 Apr; 11(2):315-324. PubMed ID: 32367987
[No Abstract] [Full Text] [Related]
16. Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding study.
Fagan SC; Waller JL; Nichols FT; Edwards DJ; Pettigrew LC; Clark WM; Hall CE; Switzer JA; Ergul A; Hess DC
Stroke; 2010 Oct; 41(10):2283-7. PubMed ID: 20705929
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 Associated Wake-Up Stroke Treated With DWI/FLAIR Mismatch Guided Intravenous Alteplase: A Case Report.
Biag E; Solis K; Abd Elazim A; Hussein O
Neurologist; 2021 Nov; 26(6):271-273. PubMed ID: 34734906
[TBL] [Abstract][Full Text] [Related]
18. Intravenous Tenecteplase for Acute Ischemic Stroke Within 4.5-24 Hours of Onset (ROSE-TNK): A Phase 2, Randomized, Multicenter Study.
Wang L; Dai YJ; Cui Y; Zhang H; Jiang CH; Duan YJ; Zhao Y; Feng YF; Geng SM; Zhang ZH; Lu J; Zhang P; Zhao LW; Zhao H; Ma YT; Song CG; Zhang Y; Chen HS
J Stroke; 2023 Sep; 25(3):371-377. PubMed ID: 37608533
[TBL] [Abstract][Full Text] [Related]
19. Results of the MRI substudy of the intravenous magnesium efficacy in stroke trial.
Kidwell CS; Lees KR; Muir KW; Chen C; Davis SM; De Silva DA; Weir CJ; Starkman S; Alger JR; Saver JL;
Stroke; 2009 May; 40(5):1704-9. PubMed ID: 19299636
[TBL] [Abstract][Full Text] [Related]
20. Cerebrolysin and early neurorehabilitation in patients with acute ischemic stroke: a prospective, randomized, placebo-controlled clinical study.
Stan A; Birle C; Blesneag A; Iancu M
J Med Life; 2017; 10(4):216-222. PubMed ID: 29362596
[No Abstract] [Full Text] [Related]
[Next] [New Search]
